By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institutes of Health expects to use $4 million over the next year to fund research to speed up development of next-generation tools for distinguishing heterogeneous states among cells in situ and enhancing their sensitivity, selectivity, scalability, and other measures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.